<DOC>
	<DOC>NCT01792622</DOC>
	<brief_summary>Develop a brief, new, patient reported outcome instrument that is valid for use in clinical practice and clinical trials.</brief_summary>
	<brief_title>Patient Reported Outcomes in Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>This study will use the Clinical Impact Method to develop a patient reported outcome for use in patients with pulmonary arterial hypertension Clinical personnel at the study sites will approach and discuss possible participation in Phase I and II of the study with subjects from the existing pool of patients currently receiving usual and customary care at the site.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Evidence of a personally signed and dated informed consent Subjects aged &gt;=18 who have documented PAH Speak English Subjects who provide written informed consent to participate in the study before being screened for the study. Patients with nonPAH Pulmonary Hypertension Physical inability to complete the interview process Subjects who are currently enrolled in an experimental drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Instrument Development</keyword>
	<keyword>Patient Reported Outcomes</keyword>
	<keyword>Pulmonary Arterial Hypertension.</keyword>
</DOC>